{
    "PMC8668943_3": [
        {
            "subject": {
                "Gene copy number": "1 copy",
                "Total group": "Total group",
                "Effect": "perinatal HIV-1 acquisition",
                "Adjustment": "birthweight and FCGR2C genotypes"
            },
            "measures": "[Univariate OR, P-value, Adjusted OR, P-value]",
            "outcomes": "[0.29, 0.007, 0.37, 0.029]"
        },
        {
            "subject": {
                "Gene copy number": "2 copies",
                "Total group": "Total group",
                "Effect": "perinatal HIV-1 acquisition",
                "Adjustment": "birthweight and FCGR2C genotypes"
            },
            "measures": "[Univariate OR, P-value, Adjusted OR, P-value]",
            "outcomes": "[Ref, , Ref, ]"
        },
        {
            "subject": {
                "Gene copy number": "\u22653 copies",
                "Total group": "Total group",
                "Effect": "perinatal HIV-1 acquisition",
                "Adjustment": "birthweight and FCGR2C genotypes"
            },
            "measures": "[Univariate OR, P-value, Adjusted OR, P-value]",
            "outcomes": "[0.99, 0.978, 0.74, 0.275]"
        }
    ],
    "PMC5817808_2": [
        {
            "subject": {
                "study population": "HIV exposed infants of the Essos hospital center PMTCT program",
                "infant mortality": "2.58%",
                "feeding option": "varying trends"
            },
            "measures": "[infant mortality]",
            "outcomes": "[2.58%]"
        },
        {
            "subject": {
                "feeding option": "ERF",
                "infant mortality": "2.41%",
                "comparison": "EBF",
                "increment": "5.4 folds"
            },
            "measures": "[infant mortality]",
            "outcomes": "[2.41%]"
        },
        {
            "subject": {
                "feeding option": "EBF",
                "infant mortality": "2.45%",
                "comparison": "ERF",
                "increment": "5.5 folds"
            },
            "measures": "[infant mortality]",
            "outcomes": "[2.45%]"
        },
        {
            "subject": {
                "feeding option": "MF",
                "infant mortality": "13.33%",
                "comparison": "EBF and ERF",
                "increment": "5.4 and 5.5 folds"
            },
            "measures": "[infant mortality]",
            "outcomes": "[13.33%]"
        },
        {
            "subject": {
                "mode of feeding": "Exclusive breast feeding",
                "unadjusted HR": "1.35",
                "unadjusted HR 95% CI": "0.52-3.49",
                "p-value": "0.76",
                "adjusted HR": "1.16",
                "adjusted HR 95% CI": "0.44-3.08"
            },
            "measures": "[unadjusted HR, adjusted HR]",
            "outcomes": "[1.35, 1.16]"
        },
        {
            "subject": {
                "mode of feeding": "Mixed feeding",
                "unadjusted HR": "0.31",
                "unadjusted HR 95% CI": "0.04-2.42",
                "p-value": "0.45",
                "adjusted HR": "0.44",
                "adjusted HR 95% CI": "0.053-3.74"
            },
            "measures": "[unadjusted HR, adjusted HR]",
            "outcomes": "[0.31, 0.44]"
        },
        {
            "subject": {
                "mode of feeding": "Exclusive replacement feeding",
                "unadjusted HR": "Ref",
                "unadjusted HR 95% CI": "Ref",
                "p-value": "Ref",
                "adjusted HR": "Ref",
                "adjusted HR 95% CI": "Ref"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "HIV- Status": "Positive",
                "unadjusted HR": "0.31",
                "unadjusted HR 95% CI": "0.11-0.90",
                "p-value": "0.071",
                "adjusted HR": "0.30",
                "adjusted HR 95% CI": "0.08-1.11"
            },
            "measures": "[unadjusted HR, adjusted HR]",
            "outcomes": "[0.31, 0.30]"
        },
        {
            "subject": {
                "HIV- Status": "Negative",
                "unadjusted HR": "Ref",
                "unadjusted HR 95% CI": "Ref",
                "p-value": "Ref",
                "adjusted HR": "Ref",
                "adjusted HR 95% CI": "Ref"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "birth weight": ">=2500 g",
                "unadjusted HR": "0.88",
                "unadjusted HR 95% CI": "0.34-2.28",
                "p-value": "0.92",
                "adjusted HR": "0.93",
                "adjusted HR 95% CI": "0.21-4.12"
            },
            "measures": "[unadjusted HR, adjusted HR]",
            "outcomes": "[0.88, 0.93]"
        },
        {
            "subject": {
                "birth weight": "<2500 g",
                "unadjusted HR": "Ref",
                "unadjusted HR 95% CI": "Ref",
                "p-value": "Ref",
                "adjusted HR": "Ref",
                "adjusted HR 95% CI": "Ref"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC5574138_3": [
        {
            "subject": {
                "study type": "meta regression",
                "dependent variable": "not specified",
                "independent variable": "length of follow-up",
                "estimate": "-0.0138",
                "standard error": "0.0666",
                "confidence interval": "(-0.1322, 0.1046)"
            },
            "measures": "[estimate]",
            "outcomes": "[-0.0138]"
        },
        {
            "subject": {
                "study type": "meta regression",
                "dependent variable": "not specified",
                "independent variable": "median CD4 count",
                "estimate": "0.0034",
                "standard error": "0.0066",
                "confidence interval": "(-0.0150, 0.0079)"
            },
            "measures": "[estimate]",
            "outcomes": "[0.0034]"
        },
        {
            "subject": {
                "study type": "meta regression",
                "dependent variable": "not specified",
                "independent variable": "median age",
                "estimate": "0.0415",
                "standard error": "0.0503",
                "confidence interval": "(-0.1013, 0.0755)"
            },
            "measures": "[estimate]",
            "outcomes": "[0.0415]"
        },
        {
            "subject": {
                "study type": "meta regression",
                "dependent variable": "not specified",
                "independent variable": "year of publication",
                "estimate": "0.0637",
                "standard error": "0.0815",
                "confidence interval": "(-0.1736, 0.0980)"
            },
            "measures": "[estimate]",
            "outcomes": "[0.0637]"
        },
        {
            "subject": {
                "study type": "meta regression",
                "dependent variable": "not specified",
                "independent variable": "female proportion",
                "estimate": "-0.5305",
                "standard error": "1.4575",
                "confidence interval": "(-3.6792, 2.6183)"
            },
            "measures": "[estimate]",
            "outcomes": "[-0.5305]"
        }
    ],
    "PMC4794224_2": [
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DL1",
                "Frequency": "97%"
            },
            "measures": "[Frequency]",
            "outcomes": "[97%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DL3",
                "Frequency": "72%"
            },
            "measures": "[Frequency]",
            "outcomes": "[72%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DL4",
                "Frequency": "100%"
            },
            "measures": "[Frequency]",
            "outcomes": "[100%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DL5",
                "Frequency": "55%"
            },
            "measures": "[Frequency]",
            "outcomes": "[55%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DL2*004",
                "Frequency": "3%"
            },
            "measures": "[Frequency]",
            "outcomes": "[3%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DL2*001/2/3/5",
                "Frequency": "55%"
            },
            "measures": "[Frequency]",
            "outcomes": "[55%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DP1",
                "Frequency": "97%"
            },
            "measures": "[Frequency]",
            "outcomes": "[97%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DS1",
                "Frequency": "55%"
            },
            "measures": "[Frequency]",
            "outcomes": "[55%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DS2",
                "Frequency": "59%"
            },
            "measures": "[Frequency]",
            "outcomes": "[59%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DS3",
                "Frequency": "40%"
            },
            "measures": "[Frequency]",
            "outcomes": "[40%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DS4",
                "Frequency": "100%"
            },
            "measures": "[Frequency]",
            "outcomes": "[100%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR2DS5",
                "Frequency": "28%"
            },
            "measures": "[Frequency]",
            "outcomes": "[28%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR3DL1",
                "Frequency": "94%"
            },
            "measures": "[Frequency]",
            "outcomes": "[94%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR3DL2",
                "Frequency": "100%"
            },
            "measures": "[Frequency]",
            "outcomes": "[100%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR3DL3",
                "Frequency": "100%"
            },
            "measures": "[Frequency]",
            "outcomes": "[100%]"
        },
        {
            "subject": {
                "Study Cohort": "studied cohort",
                "KIR Genotype": "KIR3DS1",
                "Frequency": "36%"
            },
            "measures": "[Frequency]",
            "outcomes": "[36%]"
        }
    ],
    "PMC9077443_2": [
        {
            "subject": {
                "study": "HIV infections",
                "analysis": "ITT",
                "groups": "cabotegravir and TDF-FTC",
                "HIV incidence": "0.20 per 100 person-years",
                "95% CI": "0.06\u20130.52"
            },
            "measures": "[HIV incidence]",
            "outcomes": "[0.20 per 100 person-years]"
        },
        {
            "subject": {
                "study": "HIV infections",
                "analysis": "ITT",
                "groups": "cabotegravir and TDF-FTC",
                "HIV incidence": "1.85 per 100 person-years",
                "95% CI": "1.3\u20132.57"
            },
            "measures": "[HIV incidence]",
            "outcomes": "[1.85 per 100 person-years]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Overall",
                "events": "36/1942",
                "HR": "0.12",
                "95% CI": "0.05\u20130.31",
                "p value": "<0.0001"
            },
            "measures": "[HR]",
            "outcomes": "[0.12]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Age",
                "p value": "0.53"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Age <25 years",
                "events": "20/851",
                "HR": "0.17",
                "95% CI": "0.05\u20130.54"
            },
            "measures": "[HR]",
            "outcomes": "[0.17]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Age \u226525 years",
                "events": "16/1091",
                "HR": "0.09",
                "95% CI": "0.02\u20130.49"
            },
            "measures": "[HR]",
            "outcomes": "[0.09]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Contraceptive method",
                "p value": "0.87"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "DMPA",
                "events": "21/1000",
                "HR": "0.16",
                "95% CI": "0.05\u20130.53"
            },
            "measures": "[HR]",
            "outcomes": "[0.16]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "NET-EN",
                "events": "6/182",
                "HR": "0.22",
                "95% CI": "0.03\u20131.48"
            },
            "measures": "[HR]",
            "outcomes": "[0.22]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Implant",
                "events": "8/607",
                "HR": "0.06",
                "95% CI": "0.00\u20131.16"
            },
            "measures": "[HR]",
            "outcomes": "[0.06]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Other",
                "events": "1/152",
                "HR": "0.32",
                "95% CI": "0.01\u20139.89"
            },
            "measures": "[HR]",
            "outcomes": "[0.32]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Body-mass index"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Body-mass index \u226430 kg/m\u00b2",
                "events": "27/1447",
                "HR": "0.16",
                "95% CI": "0.06\u20130.45",
                "p value": "0.47"
            },
            "measures": "[HR]",
            "outcomes": "[0.16]"
        },
        {
            "subject": {
                "study": "Cabotegravir effectiveness",
                "subgroup": "Body-mass index >30 kg/m\u00b2",
                "events": "9/495",
                "HR": "0.05",
                "95% CI": "0.00\u20130.96"
            },
            "measures": "[HR]",
            "outcomes": "[0.05]"
        }
    ],
    "PMC10294491_2": [
        {
            "subject": {
                "Trial": "DISCOVER",
                "Analysis": "primary outcome",
                "Scale": "rate ratio",
                "Group": "TDF/FTC",
                "No. subjects": "2693",
                "PYFU": "4386",
                "Incident HIV infections": "11",
                "Incidence rate": "0.251",
                "Rate ratio": "REF"
            },
            "measures": "[Incidence rate, Rate ratio]",
            "outcomes": "[0.251, REF]"
        },
        {
            "subject": {
                "Trial": "DISCOVER",
                "Analysis": "primary outcome",
                "Scale": "rate ratio",
                "Group": "TAF/FTC",
                "No. subjects": "2694",
                "PYFU": "4370",
                "Incident HIV infections": "6",
                "Incidence rate": "0.137",
                "Rate ratio": "0.55",
                "95% CI": "0.20, 1.48"
            },
            "measures": "[Incidence rate, Rate ratio]",
            "outcomes": "[0.137, 0.55]"
        },
        {
            "subject": {
                "Trial": "DISCOVER",
                "Analysis": "re-analysis",
                "Scale": "averted infections",
                "Group": "TDF/FTC",
                "PYFU": "4386",
                "Observed infections": "11",
                "Predicted infections": "90.4",
                "Averted infections": "79.4",
                "Averted infections ratio": "REF"
            },
            "measures": "[Averted infections, Averted infections ratio]",
            "outcomes": "[79.4, REF]"
        },
        {
            "subject": {
                "Trial": "DISCOVER",
                "Analysis": "re-analysis",
                "Scale": "averted infections",
                "Group": "TAF/FTC",
                "PYFU": "4370",
                "Observed infections": "6",
                "Predicted infections": "90.0",
                "Averted infections": "84.0",
                "Averted infections ratio": "1.06",
                "95% CI": "0.96, 1.17"
            },
            "measures": "[Averted infections, Averted infections ratio]",
            "outcomes": "[84.0, 1.06]"
        },
        {
            "subject": {
                "Trial": "DISCOVER",
                "Counterfactual placebo incidence rate": "2.06",
                "Unit": "per 100 PYFU",
                "Credibility limit": "lower 2.5%"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC6158807_3": [
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "CD4/CD8 ratio",
                "metric": "rate per 100 person-year",
                "outcome": "11.42"
            },
            "measures": "[rate per 100 person-year]",
            "outcomes": "[11.42]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio < 0.3",
                "metric": "rate per 100 person-year",
                "outcome": "11.42"
            },
            "measures": "[rate per 100 person-year]",
            "outcomes": "[11.42]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio 0.30-0.45",
                "metric": "rate per 100 person-year",
                "outcome": "5.64"
            },
            "measures": "[rate per 100 person-year]",
            "outcomes": "[5.64]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio > 0.45",
                "metric": "rate per 100 person-year",
                "outcome": "2.23"
            },
            "measures": "[rate per 100 person-year]",
            "outcomes": "[2.23]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "endpoint": "composite endpoint",
                "number of events": "123",
                "person-year of follow-up": "4071",
                "metric": "rate per 100 person-year",
                "outcome": "3.02"
            },
            "measures": "[rate per 100 person-year]",
            "outcomes": "[3.02]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "endpoint": "composite endpoint",
                "number of events": "123",
                "person-year of follow-up": "4071",
                "metric": "95% CI",
                "outcome": "2.53-3.61"
            },
            "measures": "[95% CI]",
            "outcomes": "[2.53-3.61]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio < 0.3",
                "number of events": "21",
                "person-year of follow-up": "184",
                "metric": "rate per 100 person-year",
                "outcome": "11.42"
            },
            "measures": "[rate per 100 person-year]",
            "outcomes": "[11.42]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio < 0.3",
                "number of events": "21",
                "person-year of follow-up": "184",
                "metric": "95% CI",
                "outcome": "7.45-17.52"
            },
            "measures": "[95% CI]",
            "outcomes": "[7.45-17.52]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio 0.30-0.45",
                "number of events": "28",
                "person-year of follow-up": "496",
                "metric": "rate per 100 person-year",
                "outcome": "5.64"
            },
            "measures": "[rate per 100 person-year]",
            "outcomes": "[5.64]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio 0.30-0.45",
                "number of events": "28",
                "person-year of follow-up": "496",
                "metric": "95% CI",
                "outcome": "3.90-8.17"
            },
            "measures": "[95% CI]",
            "outcomes": "[3.90-8.17]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio > 0.45",
                "number of events": "72",
                "person-year of follow-up": "3227",
                "metric": "rate per 100 person-year",
                "outcome": "2.23"
            },
            "measures": "[rate per 100 person-year]",
            "outcomes": "[2.23]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "cutoff": "current CD4/CD8 ratio > 0.45",
                "number of events": "72",
                "person-year of follow-up": "3227",
                "metric": "95% CI",
                "outcome": "1.77-2.81"
            },
            "measures": "[95% CI]",
            "outcomes": "[1.77-2.81]"
        },
        {
            "subject": {
                "study type": "incidence rates of non-AIDS composite events",
                "test": "long rank test",
                "p-value": "< 0.001"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC7522205_2": [
        {
            "subject": {
                "HIV-1 Genotype": "Total",
                "Patients": "%, 100.0",
                "CD4+ median (IQR)": "160 (49\u2013310)"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "CRF01_AE",
                "Patients": "%, 59.3",
                "CD4+ median (IQR)": "111 (31\u2013279)"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "CRF07_BC",
                "Patients": "%, 8.9",
                "CD4+ median (IQR)": "250 (156\u2013377)"
            },
            "measures": "[Unadjusted Coefficient, Adjusted Coefficient]",
            "outcomes": "[139, 113]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "CRF07_BC",
                "Patients": "%, 8.9",
                "CD4+ median (IQR)": "250 (156\u2013377)"
            },
            "measures": "[Unadjusted 95% CI, Adjusted 95% CI]",
            "outcomes": "[(117\u2013161), (86\u2013140)]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "CRF07_BC",
                "Patients": "%, 8.9",
                "CD4+ median (IQR)": "250 (156\u2013377)"
            },
            "measures": "[Unadjusted P, Adjusted P]",
            "outcomes": "[<0.001, <0.001]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "CRF08_BC",
                "Patients": "%, 25.6",
                "CD4+ median (IQR)": "205 (108\u2013327)"
            },
            "measures": "[Unadjusted Coefficient, Adjusted Coefficient]",
            "outcomes": "[94, 80]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "CRF08_BC",
                "Patients": "%, 25.6",
                "CD4+ median (IQR)": "205 (108\u2013327)"
            },
            "measures": "[Unadjusted 95% CI, Adjusted 95% CI]",
            "outcomes": "[(73\u2013115), (65\u201395)]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "CRF08_BC",
                "Patients": "%, 25.6",
                "CD4+ median (IQR)": "205 (108\u2013327)"
            },
            "measures": "[Unadjusted P, Adjusted P]",
            "outcomes": "[<0.001, <0.001]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "Others",
                "Patients": "%, 6.2",
                "CD4+ median (IQR)": "198 (89\u2013355)"
            },
            "measures": "[Unadjusted Coefficient, Adjusted Coefficient]",
            "outcomes": "[87, 72]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "Others",
                "Patients": "%, 6.2",
                "CD4+ median (IQR)": "198 (89\u2013355)"
            },
            "measures": "[Unadjusted 95% CI, Adjusted 95% CI]",
            "outcomes": "[(46\u2013128), (37\u2013107)]"
        },
        {
            "subject": {
                "HIV-1 Genotype": "Others",
                "Patients": "%, 6.2",
                "CD4+ median (IQR)": "198 (89\u2013355)"
            },
            "measures": "[Unadjusted P, Adjusted P]",
            "outcomes": "[<0.001, <0.001]"
        },
        {
            "subject": {
                "Study Population": "Newly diagnosed HIV patients",
                "CD4+ cell count unit": "cells/\u03bcl"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Adjustment": "Year of HIV infection diagnosis"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC7414801_2": [
        {
            "subject": {
                "study type": "as-randomized",
                "n": "382",
                "analysis type": "HIV seroconverter data",
                "visit type": "HIV detection visit"
            },
            "measures": "[HIV VL, CD4]",
            "outcomes": "[381, 382]"
        },
        {
            "subject": {
                "visit type": "M3",
                "n": "114",
                "percentage": "30"
            },
            "measures": "[HIV VL]",
            "outcomes": "[114]"
        },
        {
            "subject": {
                "visit type": "M3",
                "n": "115",
                "percentage": "30"
            },
            "measures": "[CD4]",
            "outcomes": "[115]"
        },
        {
            "subject": {
                "visit type": "M6",
                "n": "73",
                "percentage": "19"
            },
            "measures": "[HIV VL, CD4]",
            "outcomes": "[73, 73]"
        },
        {
            "subject": {
                "visit type": "M9",
                "n": "43",
                "percentage": "11"
            },
            "measures": "[HIV VL]",
            "outcomes": "[43]"
        },
        {
            "subject": {
                "visit type": "M9",
                "n": "44",
                "percentage": "12"
            },
            "measures": "[CD4]",
            "outcomes": "[44]"
        },
        {
            "subject": {
                "visit type": "M12",
                "n": "26",
                "percentage": "7"
            },
            "measures": "[HIV VL, CD4]",
            "outcomes": "[26, 26]"
        },
        {
            "subject": {
                "visit type": "M15",
                "n": "17",
                "percentage": "4"
            },
            "measures": "[HIV VL, CD4]",
            "outcomes": "[17, 17]"
        },
        {
            "subject": {
                "study type": "continuous use",
                "n": "331",
                "analysis type": "HIV seroconverter data",
                "visit type": "HIV detection visit"
            },
            "measures": "[HIV VL, CD4]",
            "outcomes": "[330, 331]"
        },
        {
            "subject": {
                "visit type": "M3",
                "n": "99",
                "percentage": "30"
            },
            "measures": "[HIV VL]",
            "outcomes": "[99]"
        },
        {
            "subject": {
                "visit type": "M3",
                "n": "99",
                "percentage": "30"
            },
            "measures": "[CD4]",
            "outcomes": "[99]"
        },
        {
            "subject": {
                "visit type": "M6",
                "n": "65",
                "percentage": "20"
            },
            "measures": "[HIV VL]",
            "outcomes": "[65]"
        },
        {
            "subject": {
                "visit type": "M6",
                "n": "64",
                "percentage": "19"
            },
            "measures": "[CD4]",
            "outcomes": "[64]"
        },
        {
            "subject": {
                "visit type": "M9",
                "n": "40",
                "percentage": "12"
            },
            "measures": "[HIV VL, CD4]",
            "outcomes": "[40, 40]"
        },
        {
            "subject": {
                "visit type": "M12",
                "n": "25",
                "percentage": "8"
            },
            "measures": "[HIV VL, CD4]",
            "outcomes": "[25, 25]"
        },
        {
            "subject": {
                "visit type": "M15",
                "n": "14",
                "percentage": "4"
            },
            "measures": "[HIV VL, CD4]",
            "outcomes": "[14, 14]"
        }
    ],
    "PMC9624454_2": [
        {
            "subject": {
                "HIV Exposure": "All children",
                "Number": "1024",
                "CMV Viremia": "314 (30.7)",
                "P Value": "NA",
                "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
            },
            "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
            "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
        },
        {
            "subject": {
                "HIV Exposure": "HIV unexposed",
                "Number": "872",
                "CMV Viremia": "253 (29.0)",
                "P Value": "NA",
                "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
            },
            "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
            "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
        },
        {
            "subject": {
                "HIV Exposure": "HIV exposed",
                "Number": "118",
                "CMV Viremia": "45 (38.1)",
                "P Value": "0.24",
                "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
            },
            "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
            "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
        },
        {
            "subject": {
                "HIV Exposure": "HIV exposed uninfected",
                "Number": "97",
                "CMV Viremia": "36 (37.1)",
                "P Value": "0.74",
                "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
            },
            "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
            "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
        },
        {
            "subject": {
                "HIV Exposure": "HIV infected",
                "Number": "15",
                "CMV Viremia": "6 (40.0)",
                "P Value": "0.012",
                "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
            },
            "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
            "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
        }
    ],
    "PMC4549947_4": [
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "executive function",
                "gender": "Females",
                "effect size": "1.3"
            },
            "measures": "[effect size]",
            "outcomes": "[1.3]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "executive function",
                "gender": "Males",
                "effect size": "3.5",
                "confidence interval": "1.5-5.5",
                "p-value": "0.008"
            },
            "measures": "[effect size, confidence interval]",
            "outcomes": "[3.5, 1.5-5.5]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "executive function",
                "race/ethnicity": "Hispanics",
                "effect size": "2.6"
            },
            "measures": "[effect size]",
            "outcomes": "[2.6]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "executive function",
                "race/ethnicity": "African American",
                "effect size": "3.1",
                "confidence interval": "2.3-3.5",
                "p-value": "0.01"
            },
            "measures": "[effect size, confidence interval]",
            "outcomes": "[3.1, 2.3-3.5]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "executive function",
                "alcohol use": "Yes",
                "effect size": "2.6"
            },
            "measures": "[effect size]",
            "outcomes": "[2.6]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "executive function",
                "gender": "Females and Males",
                "p-interaction": "0.35"
            },
            "measures": "[p-interaction]",
            "outcomes": "[0.35]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "executive function",
                "race/ethnicity": "Hispanics and African American",
                "p-interaction": "0.05"
            },
            "measures": "[p-interaction]",
            "outcomes": "[0.05]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "cognitive flexibility",
                "gender": "Females",
                "effect size": "0.9"
            },
            "measures": "[effect size]",
            "outcomes": "[0.9]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "cognitive flexibility",
                "gender": "Males",
                "effect size": "1.8",
                "confidence interval": "1.2-2.9",
                "p-value": "0.01"
            },
            "measures": "[effect size, confidence interval]",
            "outcomes": "[1.8, 1.2-2.9]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "cognitive flexibility",
                "race/ethnicity": "Hispanics",
                "effect size": "1.9"
            },
            "measures": "[effect size]",
            "outcomes": "[1.9]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "cognitive flexibility",
                "race/ethnicity": "African American",
                "effect size": "1.5"
            },
            "measures": "[effect size]",
            "outcomes": "[1.5]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "cognitive flexibility",
                "alcohol use": "Yes",
                "effect size": "1.6",
                "confidence interval": "1.4-2.4",
                "p-value": "0.03"
            },
            "measures": "[effect size, confidence interval]",
            "outcomes": "[1.6, 1.4-2.4]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "cognitive flexibility",
                "gender": "Females and Males",
                "p-interaction": "0.013"
            },
            "measures": "[p-interaction]",
            "outcomes": "[0.013]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "cognitive flexibility",
                "race/ethnicity": "Hispanics and African American",
                "p-interaction": "0.72"
            },
            "measures": "[p-interaction]",
            "outcomes": "[0.72]"
        },
        {
            "subject": {
                "SNP": "DRD2 rs6277",
                "phenotype": "cognitive flexibility",
                "alcohol use": "Yes",
                "p-interaction": "0.32"
            },
            "measures": "[p-interaction]",
            "outcomes": "[0.32]"
        }
    ],
    "PMC6694514_3": [
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-positive",
                "Adverse Event SOC": "Hepatobiliary disorders",
                "Number of Grade 3 or 4 Adverse Events": "12",
                "Percentage of Total Grade 3 or 4 Adverse Events": "30.0%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[12, 30.0%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-negative",
                "Adverse Event SOC": "Hepatobiliary disorders",
                "Number of Grade 3 or 4 Adverse Events": "15",
                "Percentage of Total Grade 3 or 4 Adverse Events": "25.0%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[15, 25.0%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-positive",
                "Adverse Event SOC": "Respiratory and thoracic disorders",
                "Number of Grade 3 or 4 Adverse Events": "7",
                "Percentage of Total Grade 3 or 4 Adverse Events": "17.5%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[7, 17.5%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-negative",
                "Adverse Event SOC": "Respiratory and thoracic disorders",
                "Number of Grade 3 or 4 Adverse Events": "13",
                "Percentage of Total Grade 3 or 4 Adverse Events": "21.7%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[13, 21.7%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-positive",
                "Adverse Event SOC": "Blood and lymphatic disorders",
                "Number of Grade 3 or 4 Adverse Events": "6",
                "Percentage of Total Grade 3 or 4 Adverse Events": "15.0%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[6, 15.0%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-negative",
                "Adverse Event SOC": "Blood and lymphatic disorders",
                "Number of Grade 3 or 4 Adverse Events": "10",
                "Percentage of Total Grade 3 or 4 Adverse Events": "16.7%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[10, 16.7%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-positive",
                "Adverse Event SOC": "Infections and infestations",
                "Number of Grade 3 or 4 Adverse Events": "3",
                "Percentage of Total Grade 3 or 4 Adverse Events": "7.5%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[3, 7.5%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-negative",
                "Adverse Event SOC": "Infections and infestations",
                "Number of Grade 3 or 4 Adverse Events": "5",
                "Percentage of Total Grade 3 or 4 Adverse Events": "8.3%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[5, 8.3%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-positive",
                "Adverse Event SOC": "Metabolism and nutrition disorders",
                "Number of Grade 3 or 4 Adverse Events": "3",
                "Percentage of Total Grade 3 or 4 Adverse Events": "7.5%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[3, 7.5%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-negative",
                "Adverse Event SOC": "Metabolism and nutrition disorders",
                "Number of Grade 3 or 4 Adverse Events": "4",
                "Percentage of Total Grade 3 or 4 Adverse Events": "6.7%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[4, 6.7%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-positive",
                "Adverse Event SOC": "Other",
                "Number of Grade 3 or 4 Adverse Events": "9",
                "Percentage of Total Grade 3 or 4 Adverse Events": "17.5%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[9, 17.5%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-negative",
                "Adverse Event SOC": "Other",
                "Number of Grade 3 or 4 Adverse Events": "13",
                "Percentage of Total Grade 3 or 4 Adverse Events": "16.7%"
            },
            "measures": "[Number of Grade 3 or 4 Adverse Events, Percentage of Total Grade 3 or 4 Adverse Events]",
            "outcomes": "[13, 16.7%]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-positive",
                "Number of Patients": "42",
                "Number of Patients with \u22651 Grade 3 or 4 AE": "20",
                "Percentage of Patients with \u22651 Grade 3 or 4 AE": "47.6%"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-negative",
                "Number of Patients": "220",
                "Number of Patients with \u22651 Grade 3 or 4 AE": "34",
                "Percentage of Patients with \u22651 Grade 3 or 4 AE": "15.5%"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-positive",
                "Number of Patients with \u22651 Grade 3 or 4 AE possibly related to treatment": "11",
                "Percentage of Patients with \u22651 Grade 3 or 4 AE possibly related to treatment": "26.2%"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Trial": "REMoxTB",
                "Patient Group": "HIV-negative",
                "Number of Patients with \u22651 Grade 3 or 4 AE possibly related to treatment": "14",
                "Percentage of Patients with \u22651 Grade 3 or 4 AE possibly related to treatment": "6.4%"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC6937831_2": [
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "Cancer",
                "Number of deaths": "6",
                "Percentage": "4%"
            },
            "measures": "[Number of deaths]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "Other diseases",
                "Number of deaths": "10",
                "Percentage": "8%"
            },
            "measures": "[Number of deaths]",
            "outcomes": "[10]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "CVD",
                "Number of deaths": "12",
                "Percentage": "9%"
            },
            "measures": "[Number of deaths]",
            "outcomes": "[12]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "Hepatic/liver-related",
                "Number of deaths": "34",
                "Percentage": "24%"
            },
            "measures": "[Number of deaths]",
            "outcomes": "[34]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "External death",
                "Number of deaths": "78",
                "Percentage": "55%"
            },
            "measures": "[Number of deaths]",
            "outcomes": "[78]"
        },
        {
            "subject": {
                "Death category": "AIDS-Related Death (ARD)",
                "Death type": "Other diseases",
                "Number of deaths": "2",
                "Percentage": "1%"
            },
            "measures": "[Number of deaths]",
            "outcomes": "[2]"
        },
        {
            "subject": {
                "Death category": "AIDS-Related Death (ARD)",
                "Death type": "Cancer",
                "Number of deaths": "8",
                "Percentage": "3%"
            },
            "measures": "[Number of deaths]",
            "outcomes": "[8]"
        },
        {
            "subject": {
                "Death category": "AIDS-Related Death (ARD)",
                "Death type": "Opportunistic",
                "Number of deaths": "241",
                "Percentage": "96%"
            },
            "measures": "[Number of deaths]",
            "outcomes": "[241]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "Cancer",
                "Cause": "Unrelated to HIV"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Death category": "AIDS-Related Death (ARD)",
                "Death type": "Cancer",
                "Cause": "AIDS-related"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "Other diseases",
                "CD4 count": "Lower than 200 cells/mm\u00b2"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "Other diseases",
                "CD4 count": "Higher than 200 cells/mm\u00b2"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "External death",
                "Cause": "Sudden death"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "External death",
                "Cause": "Accident"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "External death",
                "Cause": "Overdose"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Death category": "Non-AIDS-Related Death (NARD)",
                "Death type": "External death",
                "Cause": "Suicide"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC8340029_2": [
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "2860",
                "HIV incidence": "4.65 per 100 person-years",
                "Time period": "Before PrEP access",
                "Metrics": "HIV incidence",
                "Outcomes": "4.65 per 100 person-years"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "556",
                "HIV incidence": "2.16 per 100 person-years",
                "Time period": "After PrEP access",
                "Metrics": "HIV incidence",
                "Outcomes": "2.16 per 100 person-years"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "2860",
                "HIV incidence": "4.65 per 100 person-years",
                "Time period": "Before PrEP access",
                "Adjusted for": "study site and randomisation group",
                "Metrics": "Adjusted incidence rate ratio",
                "Outcomes": "0.45 (0.25-0.82)"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "556",
                "HIV incidence": "2.16 per 100 person-years",
                "Time period": "After PrEP access",
                "Adjusted for": "study site and randomisation group",
                "Metrics": "Adjusted incidence rate ratio",
                "Outcomes": "0.45 (0.25-0.82)"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "2860",
                "HIV incidence": "4.65 per 100 person-years",
                "Time period": "Before PrEP access",
                "p value": ".",
                "Metrics": "p value",
                "Outcomes": "0.0085"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "556",
                "HIV incidence": "2.16 per 100 person-years",
                "Time period": "After PrEP access",
                "p value": ".",
                "Metrics": "p value",
                "Outcomes": "0.0085"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "919",
                "HIV incidence": "5.00 per 100 person-years",
                "Time period": "180 days before on-site PrEP access",
                "Metrics": "HIV incidence",
                "Outcomes": "5.00 per 100 person-years"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "481",
                "HIV incidence": "2.29 per 100 person-years",
                "Time period": "180 days after on-site PrEP access",
                "Metrics": "HIV incidence",
                "Outcomes": "2.29 per 100 person-years"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "919",
                "HIV incidence": "5.00 per 100 person-years",
                "Time period": "180 days before on-site PrEP access",
                "Adjusted for": "study site, randomisation arm, age <24 years, woman reporting her partner had other partners, any unprotected sex, and any new partner",
                "Metrics": "Adjusted incidence rate ratio",
                "Outcomes": "0.44 (0.23-0.85)"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "481",
                "HIV incidence": "2.29 per 100 person-years",
                "Time period": "180 days after on-site PrEP access",
                "Adjusted for": "study site, randomisation arm, age <24 years, woman reporting her partner had other partners, any unprotected sex, and any new partner",
                "Metrics": "Adjusted incidence rate ratio",
                "Outcomes": "0.44 (0.23-0.85)"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "919",
                "HIV incidence": "5.00 per 100 person-years",
                "Time period": "180 days before on-site PrEP access",
                "p value": ".",
                "Metrics": "p value",
                "Outcomes": "0.015"
            }
        },
        {
            "subject": {
                "Study type": "HIV seroconversions",
                "Number of person-years": "481",
                "HIV incidence": "2.29 per 100 person-years",
                "Time period": "180 days after on-site PrEP access",
                "p value": ".",
                "Metrics": "p value",
                "Outcomes": "0.015"
            }
        }
    ],
    "PMC8391097_3": [
        {
            "subject": {
                "PrEP status": "Overall",
                "HIV infections": "91/13 861",
                "Total follow-up": "26 210 person-years",
                "Incidence": "0.35",
                "95% CI": "0.28-0.43"
            },
            "measures": "[Incidence]",
            "outcomes": "[0.35]"
        },
        {
            "subject": {
                "PrEP status": "Linked but not prescribed PrEP",
                "HIV infections": "36/3013",
                "Total follow-up": "4119 person-years",
                "Incidence": "0.87",
                "95% CI": "0.63-1.21"
            },
            "measures": "[Incidence]",
            "outcomes": "[0.87]"
        },
        {
            "subject": {
                "PrEP status": "Prescribed PrEP but did not initiate",
                "HIV infections": "13/811",
                "Total follow-up": "1226 person-years",
                "Incidence": "1.06",
                "95% CI": "0.62-1.83"
            },
            "measures": "[Incidence]",
            "outcomes": "[1.06]"
        },
        {
            "subject": {
                "PrEP status": "Discontinued but reinitiated PrEP",
                "HIV infections": "4/1082",
                "Total follow-up": "1420 person-years",
                "Incidence": "0.28",
                "95% CI": "0.11-0.75"
            },
            "measures": "[Incidence]",
            "outcomes": "[0.28]"
        },
        {
            "subject": {
                "PrEP status": "Discontinued and did not reinitiate PrEP",
                "HIV infections": "38/2108",
                "Total follow-up": "2973 person-years",
                "Incidence": "1.28",
                "95% CI": "0.93-1.76"
            },
            "measures": "[Incidence]",
            "outcomes": "[1.28]"
        },
        {
            "subject": {
                "PrEP status": "Persistent on PrEP",
                "HIV infections": "0/5367",
                "Total follow-up": "9139 person-years",
                "Incidence": "0.00",
                "95% CI": "0.00-0.04"
            },
            "measures": "[Incidence]",
            "outcomes": "[0.00]"
        }
    ],
    "PMC8748440_2": [
        {
            "subject": {
                "Gene": "ISG15",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.29",
                "95% CI for HR": "0.11\u20130.81",
                "p value": "0.0091"
            },
            "measures": "[HR]",
            "outcomes": "[0.29]"
        },
        {
            "subject": {
                "Gene": "IFI6",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.18",
                "95% CI for HR": "0.037\u20130.86",
                "p value": "0.014"
            },
            "measures": "[HR]",
            "outcomes": "[0.18]"
        },
        {
            "subject": {
                "Gene": "IFI44L",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.55",
                "95% CI for HR": "0.27\u20131.1",
                "p value": "0.083"
            },
            "measures": "[HR]",
            "outcomes": "[0.55]"
        },
        {
            "subject": {
                "Gene": "IFI44",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.23",
                "95% CI for HR": "0.047\u20131.2",
                "p value": "0.045"
            },
            "measures": "[HR]",
            "outcomes": "[0.23]"
        },
        {
            "subject": {
                "Gene": "IFIT1",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.37",
                "95% CI for HR": "0.12\u20131.1",
                "p value": "0.054"
            },
            "measures": "[HR]",
            "outcomes": "[0.37]"
        },
        {
            "subject": {
                "Gene": "OAS3",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.52",
                "95% CI for HR": "0.22\u20131.3",
                "p value": "0.15"
            },
            "measures": "[HR]",
            "outcomes": "[0.52]"
        },
        {
            "subject": {
                "Gene": "XAF1",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.3",
                "95% CI for HR": "0.1\u20130.92",
                "p value": "0.027"
            },
            "measures": "[HR]",
            "outcomes": "[0.3]"
        },
        {
            "subject": {
                "Gene": "TRIM25",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.074",
                "95% CI for HR": "0.0068\u20130.8",
                "p value": "0.023"
            },
            "measures": "[HR]",
            "outcomes": "[0.074]"
        },
        {
            "subject": {
                "Gene": "CMPK2",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.23",
                "95% CI for HR": "0.037\u20131.5",
                "p value": "0.074"
            },
            "measures": "[HR]",
            "outcomes": "[0.23]"
        },
        {
            "subject": {
                "Gene": "RSAD2",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.2",
                "95% CI for HR": "0.041\u20130.99",
                "p value": "0.032"
            },
            "measures": "[HR]",
            "outcomes": "[0.2]"
        },
        {
            "subject": {
                "Gene": "EIF2AK2",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.54",
                "95% CI for HR": "0.12\u20132.4",
                "p value": "0.42"
            },
            "measures": "[HR]",
            "outcomes": "[0.54]"
        },
        {
            "subject": {
                "Gene": "USP18",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.23",
                "95% CI for HR": "0.062\u20130.84",
                "p value": "0.022"
            },
            "measures": "[HR]",
            "outcomes": "[0.23]"
        },
        {
            "subject": {
                "Gene": "HERC6",
                "Module": "Module 1",
                "Analysis": "Univariable Cox regression",
                "HR": "0.16",
                "95% CI for HR": "0.019\u20131.3",
                "p value": "0.057"
            },
            "measures": "[HR]",
            "outcomes": "[0.16]"
        },
        {
            "subject": {
                "Gene": "ISG15",
                "Module": "Module 1",
                "Analysis": "Multivariable Cox Regression",
                "cor": "-0.41"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Gene": "TRIM25",
                "Module": "Module 1",
                "Analysis": "Multivariable Cox Regression",
                "cor": "-0.32"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Gene": "XAF1",
                "Module": "Module 1",
                "Analysis": "Multivariable Cox Regression",
                "cor": "-0.06"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Gene": "USP18",
                "Module": "Module 1",
                "Analysis": "Multivariable Cox Regression",
                "cor": "-0.14"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC7615197_2": [
        {
            "subject": {
                "study arm": "dexamethasone",
                "number of patients": "263",
                "number of deaths": "116",
                "hazard ratio": "0.85",
                "confidence interval": "0.66-1.10",
                "p value": "0.22",
                "test for proportional hazards": "0.36",
                "p value for heterogeneity": ""
            },
            "measures": "[hazard ratio]",
            "outcomes": "[0.85]"
        },
        {
            "subject": {
                "study arm": "placebo",
                "number of patients": "257",
                "number of deaths": "126",
                "hazard ratio": "",
                "confidence interval": "",
                "p value": "",
                "test for proportional hazards": "",
                "p value for heterogeneity": ""
            },
            "measures": "[hazard ratio]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "population": "intention-to-treat population",
                "study arm": "dexamethasone",
                "number of patients": "263",
                "number of deaths": "116",
                "hazard ratio": "0.85",
                "confidence interval": "0.66-1.10",
                "p value": "0.22",
                "test for proportional hazards": "0.36",
                "p value for heterogeneity": ""
            },
            "measures": "[hazard ratio]",
            "outcomes": "[0.85]"
        },
        {
            "subject": {
                "population": "intention-to-treat population",
                "study arm": "placebo",
                "number of patients": "257",
                "number of deaths": "126",
                "hazard ratio": "",
                "confidence interval": "",
                "p value": "",
                "test for proportional hazards": "",
                "p value for heterogeneity": ""
            },
            "measures": "[hazard ratio]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "MRC grade": "Grade I",
                "study arm": "dexamethasone",
                "number of patients": "99",
                "number of deaths": "22",
                "hazard ratio": "0.72",
                "confidence interval": "0.41-1.25",
                "p value": "0.24",
                "test for proportional hazards": "0.15",
                "p value for heterogeneity": "0.63"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[0.72]"
        },
        {
            "subject": {
                "MRC grade": "Grade I",
                "study arm": "placebo",
                "number of patients": "97",
                "number of deaths": "28",
                "hazard ratio": "",
                "confidence interval": "",
                "p value": "",
                "test for proportional hazards": "",
                "p value for heterogeneity": "0.63"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "MRC grade": "Grade II",
                "study arm": "dexamethasone",
                "number of patients": "125",
                "number of deaths": "60",
                "hazard ratio": "0.82",
                "confidence interval": "0.58-1.16",
                "p value": "0.27",
                "test for proportional hazards": "0.57",
                "p value for heterogeneity": "0.63"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[0.82]"
        },
        {
            "subject": {
                "MRC grade": "Grade II",
                "study arm": "placebo",
                "number of patients": "126",
                "number of deaths": "68",
                "hazard ratio": "",
                "confidence interval": "",
                "p value": "",
                "test for proportional hazards": "",
                "p value for heterogeneity": "0.63"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "MRC grade": "Grade III",
                "study arm": "dexamethasone",
                "number of patients": "39",
                "number of deaths": "34",
                "hazard ratio": "1.11",
                "confidence interval": "0.70-1.77",
                "p value": "0.65",
                "test for proportional hazards": "0.89",
                "p value for heterogeneity": "0.63"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[1.11]"
        },
        {
            "subject": {
                "MRC grade": "Grade III",
                "study arm": "placebo",
                "number of patients": "34",
                "number of deaths": "30",
                "hazard ratio": "",
                "confidence interval": "",
                "p value": "",
                "test for proportional hazards": "",
                "p value for heterogeneity": "0.63"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[]"
        }
    ],
    "PMC9008168_2": [
        {
            "subject": {
                "HIV status": "without HIV",
                "ART status": "none",
                "Incidence rate type": "unadjusted",
                "Incidence rate": "69.8",
                "95% CI": "Reference",
                "HR": "1.00"
            },
            "measures": "[Incidence rate, HR]",
            "outcomes": "[69.8, 1.00]"
        },
        {
            "subject": {
                "HIV status": "with HIV",
                "ART status": "non-TLD ART",
                "Incidence rate type": "unadjusted",
                "Incidence rate": "77.1",
                "95% CI": "0.79\u20131.63",
                "HR": "1.13"
            },
            "measures": "[Incidence rate, HR]",
            "outcomes": "[77.1, 1.13]"
        },
        {
            "subject": {
                "HIV status": "with HIV",
                "ART status": "TLD",
                "Incidence rate type": "unadjusted",
                "Incidence rate": "73.3",
                "95% CI": "1.22\u20132.55",
                "HR": "1.77"
            },
            "measures": "[Incidence rate, HR]",
            "outcomes": "[73.3, 1.77]"
        },
        {
            "subject": {
                "HIV status": "with HIV",
                "ART status": "ART na\u00efve",
                "Incidence rate type": "unadjusted",
                "Incidence rate": "37.7",
                "95% CI": "0.27\u20130.70",
                "HR": "0.43"
            },
            "measures": "[Incidence rate, HR]",
            "outcomes": "[37.7, 0.43]"
        }
    ],
    "PMC7644038_3": [
        {
            "subject": {
                "Condition": "Depression",
                "HIV status": "HIV",
                "Age": "65",
                "Year": "2011-2016",
                "Population": "Medicare beneficiaries",
                "Unadjusted": "Yes"
            },
            "measures": "[Prevalence]",
            "outcomes": "[24.3%]"
        },
        {
            "subject": {
                "Condition": "Depression",
                "HIV status": "No HIV",
                "Age": "65",
                "Year": "2011-2016",
                "Population": "Medicare beneficiaries",
                "Unadjusted": "Yes"
            },
            "measures": "[Prevalence]",
            "outcomes": "[6.2%]"
        },
        {
            "subject": {
                "Condition": "Depression",
                "HIV status": "No HIV",
                "Age": "65",
                "Year": "2011-2016",
                "Population": "Medicare beneficiaries",
                "Unadjusted": "Yes"
            },
            "measures": "[Percent difference]",
            "outcomes": "[291.9%]"
        },
        {
            "subject": {
                "Condition": "Depression",
                "HIV status": "HIV",
                "Age": "65",
                "Year": "2016",
                "Population": "Medicare beneficiaries",
                "Model": "Logistic regression"
            },
            "measures": "[Odds ratio]",
            "outcomes": "[2.29]"
        },
        {
            "subject": {
                "Condition": "Depression",
                "HIV status": "HIV",
                "Age": "65",
                "Year": "2016",
                "Population": "Medicare beneficiaries",
                "Model": "Logistic regression"
            },
            "measures": "[95% CI]",
            "outcomes": "[2.22, 2.35]"
        },
        {
            "subject": {
                "Condition": "Chronic kidney disease",
                "HIV status": "HIV",
                "Age": "65",
                "Year": "2011-2016",
                "Population": "Medicare beneficiaries",
                "Unadjusted": "Yes"
            },
            "measures": "[Prevalence]",
            "outcomes": "[46.2%]"
        },
        {
            "subject": {
                "Condition": "Chronic kidney disease",
                "HIV status": "No HIV",
                "Age": "65",
                "Year": "2011-2016",
                "Population": "Medicare beneficiaries",
                "Unadjusted": "Yes"
            },
            "measures": "[Prevalence]",
            "outcomes": "[18.9%]"
        },
        {
            "subject": {
                "Condition": "Chronic kidney disease",
                "HIV status": "No HIV",
                "Age": "65",
                "Year": "2011-2016",
                "Population": "Medicare beneficiaries",
                "Unadjusted": "Yes"
            },
            "measures": "[Percent difference]",
            "outcomes": "[144.4%]"
        },
        {
            "subject": {
                "Condition": "Chronic kidney disease",
                "HIV status": "HIV",
                "Age": "65",
                "Year": "2016",
                "Population": "Medicare beneficiaries",
                "Model": "Logistic regression"
            },
            "measures": "[Odds ratio]",
            "outcomes": "[1.92]"
        },
        {
            "subject": {
                "Condition": "Chronic kidney disease",
                "HIV status": "HIV",
                "Age": "65",
                "Year": "2016",
                "Population": "Medicare beneficiaries",
                "Model": "Logistic regression"
            },
            "measures": "[95% CI]",
            "outcomes": "[1.88, 1.97]"
        }
    ],
    "PMC6033411_2": [
        {
            "subject": {
                "Characteristic": "Age (years)",
                "Total number": "200",
                "N (%)": "34.5%",
                "metric": "Odds ratio",
                "outcome": "1.0 (ref)",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "Age (years)",
                "Category": "15 and younger",
                "Total number": "69",
                "N (%)": "37.3%",
                "Clustered": "22",
                "metric": "Odds ratio",
                "outcome": "1.0 (ref)",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "Age (years)",
                "Category": "16",
                "Total number": "46",
                "N (%)": "22%",
                "Clustered": "13",
                "metric": "Odds ratio",
                "outcome": "0.84 (0.36\u20131.89)",
                "P-value": "0.67"
            }
        },
        {
            "subject": {
                "Characteristic": "Age (years)",
                "Category": "17+",
                "Total number": "85",
                "N (%)": "40.7%",
                "Clustered": "24",
                "metric": "Odds ratio",
                "outcome": "0.87 (0.43\u20131.76)",
                "P-value": "0.69"
            }
        },
        {
            "subject": {
                "Characteristic": "School grade",
                "Total number": "200",
                "N (%)": "\u2026",
                "metric": "Odds ratio",
                "outcome": "\u2026",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "School grade",
                "Category": "8\u20139",
                "Total number": "90",
                "N (%)": "50.8%",
                "Clustered": "30",
                "metric": "Odds ratio",
                "outcome": "1.0 (ref)",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "School grade",
                "Category": "10\u201312",
                "Total number": "110",
                "N (%)": "49.2%",
                "Clustered": "29",
                "metric": "Odds ratio",
                "outcome": "0.8 (0.43\u20131.52)",
                "P-value": "0.5"
            }
        },
        {
            "subject": {
                "Characteristic": "Household income (R)",
                "Total number": "200",
                "N (%)": "\u2026",
                "metric": "Odds ratio",
                "outcome": "\u2026",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "Household income (R)",
                "Category": "<999",
                "Total number": "61",
                "N (%)": "37.3%",
                "Clustered": "22",
                "metric": "Odds ratio",
                "outcome": "1.0 (ref)",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "Household income (R)",
                "Category": "10,000\u201399,000",
                "Total number": "112",
                "N (%)": "45.8%",
                "Clustered": "27",
                "metric": "Odds ratio",
                "outcome": "0.56 (0.29\u20131.11)",
                "P-value": "0.1"
            }
        },
        {
            "subject": {
                "Characteristic": "Household income (R)",
                "Category": ">100,000",
                "Total number": "27",
                "N (%)": "16.9%",
                "Clustered": "10",
                "metric": "Odds ratio",
                "outcome": "1.04 (0.39\u20132.65)",
                "P-value": "0.93"
            }
        },
        {
            "subject": {
                "Characteristic": "CD4 cell count, cells/mm\u00b3",
                "Total number": "200",
                "N (%)": "\u2026",
                "metric": "Odds ratio",
                "outcome": "\u2026",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "CD4 cell count, cells/mm\u00b3",
                "Category": ">500",
                "Total number": "92",
                "N (%)": "50.9%",
                "Clustered": "30",
                "metric": "Odds ratio",
                "outcome": "1.0 (ref)",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "CD4 cell count, cells/mm\u00b3",
                "Category": "\u2264500",
                "Total number": "75",
                "N (%)": "32.2%",
                "Clustered": "19",
                "metric": "Odds ratio",
                "outcome": "0.70 (0.35\u20131.37)",
                "P-value": "0.31"
            }
        },
        {
            "subject": {
                "Characteristic": "CD4 cell count, cells/mm\u00b3",
                "Category": "\u2264250",
                "Total number": "15",
                "N (%)": "6.8%",
                "Clustered": "4",
                "metric": "Odds ratio",
                "outcome": "0.75 (0.2\u20132.4)",
                "P-value": "0.65"
            }
        },
        {
            "subject": {
                "Characteristic": "Major drug resistance mutation",
                "Total number": "200",
                "N (%)": "\u2026",
                "metric": "Odds ratio",
                "outcome": "\u2026",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "Major drug resistance mutation",
                "Category": "No",
                "Total number": "180",
                "N (%)": "93.2%",
                "Clustered": "55",
                "metric": "Odds ratio",
                "outcome": "1.0 (ref)",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "Major drug resistance mutation",
                "Category": "Yes",
                "Total number": "20",
                "N (%)": "6.8%",
                "Clustered": "4",
                "metric": "Odds ratio",
                "outcome": "0.57 (0.16\u20131.63)",
                "P-value": "0.33"
            }
        },
        {
            "subject": {
                "Characteristic": "HSV-2 infection",
                "Total number": "200",
                "N (%)": "\u2026",
                "metric": "Odds ratio",
                "outcome": "\u2026",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "HSV-2 infection",
                "Category": "No",
                "Total number": "90",
                "N (%)": "42.4%",
                "Clustered": "25",
                "metric": "Odds ratio",
                "outcome": "1.0 (ref)",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "HSV-2 infection",
                "Category": "Yes",
                "Total number": "69",
                "N (%)": "39%",
                "Clustered": "23",
                "metric": "Odds ratio",
                "outcome": "1.3 (0.65\u20132.57)",
                "P-value": "0.45"
            }
        },
        {
            "subject": {
                "Characteristic": "Ever pregnant",
                "Total number": "200",
                "N (%)": "\u2026",
                "metric": "Odds ratio",
                "outcome": "\u2026",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "Ever pregnant",
                "Category": "No",
                "Total number": "122",
                "N (%)": "62.7%",
                "Clustered": "37",
                "metric": "Odds ratio",
                "outcome": "1.0 (ref)",
                "P-value": "\u2026"
            }
        },
        {
            "subject": {
                "Characteristic": "Ever pregnant",
                "Category": "Yes",
                "Total number": "49",
                "N (%)": "25.4%",
                "Clustered": "15",
                "metric": "Odds ratio",
                "outcome": "1.01 (0.48\u20132.06)",
                "P-value": "0.971"
            }
        }
    ]
}